Others have shown that infiltrating monocytes expressing high levels of Thbs1 and Vegfa, two genes from our TBI-induced Immunosuppressive signature, can inhibit the efficacy of αPD-L1 treatments against Lewis lung carcinoma tumors49. The gene discussed is THBS1; the disease is Carcinoma, Lewis Lung.